title: Response: anticipating new medications.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Bogenschutz
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: DeMarzo
authors.forename: John
authors.initials: J
authors.lastname: Roll
mesh_terms: D019969:Amphetamine-Related Disorders / Q000534:rehabilitation*; D003042:Cocaine / Q000009:adverse effects; D019970:Cocaine-Related Disorders / Q000534:rehabilitation*; D006801:Humans; D008694:Methamphetamine / Q000009:adverse effects; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D009294:Narcotics / Q000009:adverse effects / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000534:rehabilitation; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D055502:Secondary Prevention; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000534:rehabilitation
chemical_list: D009292:Narcotic Antagonists; D009294:Narcotics; D011619:Psychotropic Drugs; D008694:Methamphetamine; D003042:Cocaine